179 related articles for article (PubMed ID: 9569039)
1. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology.
Harvey P; Warn A; Dobbin S; Arakaki N; Daikuhara Y; Jaurand MC; Warn RM
Br J Cancer; 1998 Apr; 77(7):1052-9. PubMed ID: 9569039
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM
J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
[TBL] [Abstract][Full Text] [Related]
3. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.
Warn R; Harvey P; Warn A; Foley-Comer A; Heldin P; Versnel M; Arakaki N; Daikuhara Y; Laurent GJ; Herrick SE; Mutsaers SE
Exp Cell Res; 2001 Jul; 267(2):258-66. PubMed ID: 11426944
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
Klominek J; Baskin B; Liu Z; Hauzenberger D
Int J Cancer; 1998 Apr; 76(2):240-9. PubMed ID: 9537587
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma.
Kuhnen C; Tolnay E; Steinau HU; Voss B; Müller KM
Virchows Arch; 1998 Apr; 432(4):337-42. PubMed ID: 9565343
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the met receptor in mesothelioma.
Mukohara T; Civiello G; Davis IJ; Taffaro ML; Christensen J; Fisher DE; Johnson BE; Jänne PA
Clin Cancer Res; 2005 Nov; 11(22):8122-30. PubMed ID: 16299245
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR
Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas.
Thirkettle I; Harvey P; Hasleton PS; Ball RY; Warn RM
Histopathology; 2000 Jun; 36(6):522-8. PubMed ID: 10849094
[TBL] [Abstract][Full Text] [Related]
11. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
12. Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.
Yi S; Chen JR; Viallet J; Schwall RH; Nakamura T; Tsao MS
Br J Cancer; 1998 Jun; 77(12):2162-70. PubMed ID: 9649128
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group.
Levallet G; Vaisse-Lesteven M; Le Stang N; Ilg AG; Brochard P; Astoul P; Pairon JC; Bergot E; Zalcman G; Galateau-Sallé F
J Thorac Oncol; 2012 Mar; 7(3):599-606. PubMed ID: 22246193
[TBL] [Abstract][Full Text] [Related]
14. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG
Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931
[TBL] [Abstract][Full Text] [Related]
15. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
Moriyama T; Kataoka H; Koono M; Wakisaka S
Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4.
Hiscox S; Parr C; Nakamura T; Matsumoto K; Mansel RE; Jiang WG
Breast Cancer Res Treat; 2000 Feb; 59(3):245-54. PubMed ID: 10832594
[TBL] [Abstract][Full Text] [Related]
19. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
Gmyrek GA; Walburg M; Webb CP; Yu HM; You X; Vaughan ED; Vande Woude GF; Knudsen BS
Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
[TBL] [Abstract][Full Text] [Related]
20. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.
Woolf AS; Kolatsi-Joannou M; Hardman P; Andermarcher E; Moorby C; Fine LG; Jat PS; Noble MD; Gherardi E
J Cell Biol; 1995 Jan; 128(1-2):171-84. PubMed ID: 7822413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
